Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Jolana Markovà, Ute Essner, Bülent Akmaz, Marcella Marinelli, Christiane Trompke, Arnd Lentschat, Carlos Vila
Institutions: Thomayer University Hospital, Almirall (Germany), Almirall (Spain)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Almirall
OpenAlex ID: W2803556125
